Lung cancer trial recreated using patient records – no new drugs needed

This completed study looked at nearly 5,000 people with non-small cell lung cancer to see if information from electronic health records could produce the same results as a famous clinical trial called FLAURA. Researchers compared patients who started taking osimertinib to those on older drugs (erlotinib or gefitinib) using real-world data. The goal was not to test a new treatment, but to learn whether real-world data can be trusted to answer important medical questions.